Concepedia

Phase II Trial of Neoadjuvant Therapy with Carboplatin, Gemcitabine plus Thalidomide for Stages IIB and III Non-small Cell Lung Cancer

Arkadiusz Z. Dudek, Krzysztof Leśniewski-Kmak, Timothy Larson, Konstantin H. Dragnev, Rachel Isaksson, Vinita Gupta, Michael A. Maddaus, Robert A. Kratzke

Journal of Thoracic Oncology · 2009 · 10 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Cancer Statistics, 2008

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2008 · 10.2K citations · Full text

, , +16

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

, , +13

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti et al. · Journal of Clinical Oncology · 2008 · 2.7K citations · Full text

, , +13

Thalidomide is an inhibitor of angiogenesis.

Robert J. D’Amato, Michael Loughnan, Evelyn Flynn et al. · Proceedings of the National Academy of Sciences · 1994 · 2.5K citations

, , +14

Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer

New England Journal of Medicine · 2004 · 2.4K citations

, , +14